APLS Archives - Market Exclusive

Home Tags APLS

Apellis Pharmaceuticals Inc (NASDAQ:APLS) gets downgraded to Neutral by JPMorgan Chase...

ME Staff - January 23, 2019

Apellis Pharmaceuticals Inc (NASDAQ:APLS) had its Buy rating reiterated by Cantor...

ME Staff - December 20, 2018

Apellis Pharmaceuticals Inc (NASDAQ:APLS) price target raised to $40.00 by Citigroup

ME Staff - December 6, 2018

Apellis Pharmaceuticals Inc (NASDAQ:APLS) price target set to $53.00 by Cantor...

ME Staff - December 3, 2018

Apellis Pharmaceuticals Inc (NASDAQ:APLS) gets upgraded to Buy by B. Riley...

ME Staff - July 30, 2018

Analyst Downgrades – NASDAQ:APLS – Apellis Pharmaceuticals (NASDAQ:APLS) Stock Gets Downgraded...

ME Staff - April 12, 2018

Analyst Activity – JPMorgan Chase & Co. Raises Its Price Target...

ME Staff - March 23, 2018

Analyst Activity – JPMorgan Chase & Co. Reiterates Overweight on Apellis...

ME Staff - March 23, 2018

Analyst Activity – B. Riley Initiates Coverage On Apellis Pharmaceuticals (NASDAQ:APLS)...

ME Staff - February 8, 2018

/* */

EDITOR PICKS

Cannabis Stock News Daily Roundup April 15

April 15, 2019

Canopy Growth Spectrum Cannabis Targets Canadians Seniors

April 15, 2019

Cannabis Stock News Daily Roundup April 12

April 12, 2019

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

November 8, 2017

ABOUT US

Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.

Tag: APLS